On Saturday 4 Oct, the European Commission (EC) published its assessment of the bids by 19
Member States to host the European Medicines Agency (EMA) when it relocates from London in March 2019.
As instructed by the Member States, the EC has been careful to avoid betraying any preference by producing a ranking or short list. The assessment is confined to a factual and objective analysis of the bids by reference to the six decision criteria determined by the Member States: premises, accessibility, education facilities for the children of staff, labour market, social security and medical care for partners of staff, business continuity and geographical spread. These criteria will be un-weighted when the Member States come to take their final decision by sequential rounds of voting in November 2017. Each Member State has the same number of votes to cast in each round and the scope for political horse trading within competing blocs is obvious.